CAMBRIDGE, Mass.--(BUSINESS WIRE)--Curis, Inc. (NASDAQ: CRIS), a therapeutic drug development company focusing on cancer, neurological and dermatological disease indications, today announced that the company will be presenting at the Mass Opportunities Annual Investors Conference, being held on Thursday, November 2nd, at the Hilton Logan Airport in Boston, Mass. The company’s presentation will take place from 9:50 a.m. to 10:10 a.m. in the New England Ballroom A.
